Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02NMO
|
||||
Former ID |
DPR000047
|
||||
Drug Name |
FR-79620
|
||||
Synonyms |
3-(5-methyl-2-phenyl-1H-imidazol-4-yl)pyridine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Eating disorder; Obesity; Diabetes [ICD9: 250, 278, 307.5; ICD10:E08-E13, E66, F50] | Preclinical | [536122] | ||
Company |
Fujisawa
|
||||
Structure |
Download2D MOL |
||||
Formula |
C15H13N3
|
||||
Canonical SMILES |
CC1=C(N=C(N1)C2=CC=CC=C2)C3=CN=CC=C3
|
||||
InChI |
1S/C15H13N3/c1-11-14(13-8-5-9-16-10-13)18-15(17-11)12-6-3-2-4-7-12/h2-10H,1H3,(H,17,18)
|
||||
InChIKey |
CAQAIFUDUGDPFB-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Neuropeptide Y receptor 5 | Target Info | Antagonist | [536122] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.